Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biotechnology Index NYSE ETF (NY: FBT )

162.68 USD +2.66 (+1.66%)
Official Closing Price Updated: 8:00 PM EDT, May 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biotechnology Index NYSE ETF

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from... 
Tags Pharma/Biotech Stocks / Equities ETFs
From Blogs - TalkMarkets
Analysts Forecast 22% Upside For The Holdings of FBT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
How The Parts Add Up: FBT Targets $211
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
FBT's Underlying Holdings Could Mean 16% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Analysts Expect FBT To Hit $207
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
How The Pieces Add Up: FBT Targets $202
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Analysts Anticipate 20% Gains Ahead For The Holdings of FBT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover
The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when ... 
Tags AZN Top Stories PBE
From Benzinga
ETF Sectors to Bet on Positive Vaccine News
The aggravating coronavirus outbreak in the United States and globally is definitely increasing the desperation for a vaccine 
Tags Financial Energy ETFs
From Blogs - TalkMarkets
Large Cap Biopharma Performance and Metrics Q3 2020; ETFs Are Winners
Surging coronavirus infections has even nicked the healthcare sector down 3% for the week. 
Tags Pharma/Biotech Healthcare ETFs
From Blogs - TalkMarkets
Thursday's ETF Movers: TAN, FBT
In trading on Thursday, the Invesco Solar ETF is outperforming other ETFs, up about 10.9% on the day. Components of that ETF showing particular strength include shares of Jinkosolar Holding, up about... 
Tags ETFs
From ETF Channel
Wednesday's ETF Movers: FBT, KRE
In trading on Wednesday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 6.4% on the day. Components of that ETF showing particular strength include shares... 
Tags ETFs
From ETF Channel
Can’t Get Enough Biotech Exposure in Your Portfolio?
As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds,... 
Tags FBT tactical allocation channel biotech
From ETF Trends
Not Enough Biotech in Your Portfolio?
As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds,... 
From ETFdb
ETF Wrap: the Groundhog Day of fiscal stimulus talks and the bet on volatility
ETF Wrap is a briefing of what investors need to know in the exchange-traded fund sector, including exclusive commentary and interviews on the industry from MarketWatch 
Tags SPY BX:TMUBMUSD10Y VTI
From MarketWatch
Encouraging Election Year History for this Biotech ETF
Healthcare is one of the most politically sensitive sectors and that sensitivity is on full display in recent weeks with biotechnology ETFs, including the First Trust NYSE Arca Biotechnology Index Fund... 
Tags alternatives channel biotech etf FBT
From ETF Trends
Election History Says Buy Biotech Dip
Biotechnology exchange-traded funds were hot until they weren't. History indicates recent weakness in the previously high-flying ... 
Tags Sector ETFs Long Ideas Benzinga
From Benzinga
We Did The Math FBT Can Go To $198
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Tuesday's ETF Movers: WCLD, FBT
In trading on Tuesday, the WisdomTree Cloud Computing Fund ETF is outperforming other ETFs, up about 4% on the day. Components of that ETF showing particular strength include shares of Zoom Video... 
Tags ETFs
From ETF Channel
Best & Worst Monthly Performers: August 26 Edition
Here is a look at the 25 best and 25 worst ETFs from the past trading month. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby... 
From ETFdb
Post-Pandemic Stars Could Align For This Biotech ETF
These days, it's not hard to find winners among health care exchange-traded funds and that's true of both established and rookie ... 
Tags Long Ideas Benzinga MRNA
From Benzinga
We Did The Math FBT Can Go To $196
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Red Hot ETF Areas Amid The Coronavirus Crisis
Some ETF areas that will continue to be strong investing options through the pandemic will be internet, biotech and sustainable investing ETFs. 
Tags ETFs Technology Pharma/Biotech
From Blogs - TalkMarkets
Biotech Portfolio Review: What To Do Next?
Your biotech portfolio is probably up at least 10% YTD because the IBB is up ~17% and the XBI up 18.35%. Do you raise cash or go more defensive with the life science positions you own? 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Biotech ETFs To Gain As Coronavirus Vaccine Hopes Strengthen
The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide... 
Tags Stocks / Equities ETFs Pharma/Biotech
From Blogs - TalkMarkets
Analysts Forecast 13% Gains Ahead For FBT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biotech ETFs Still Promising Despite Hydroxychloroquine Trial
In the continuing quest to find a vaccine for the coronavirus, the World Health Organization announced Wednesday it is dropping hydroxychloroquine, the malaria drug backed by President Trump, who... 
Tags biotech etfs BBH Dexamethasone
From ETF Trends
There’s Still Plenty of Opportunity for Biotech Post-Coronavirus
While the Coronavirus pandemic continues dominating healthcare sector headlines, investors shouldn’t fret that biotechnology ETFs will be left vulnerable when the virus is finally vanquished. That’s... 
Tags thematic investing channel coronavirus FBT
From ETF Trends
There's Plenty of Opportunity for Biotech Post-Coronavirus
While the Coronavirus pandemic continues dominating healthcare sector headlines, investors shouldn’t fret that biotechnology ETFs will be left vulnerable when the virus is finally vanquished. That’s... 
From ETFdb
Coronavirus Makes Biotech ETFs Red Hot
Biotech ETFs are surging with many hitting new 52-week highs lately. 
Tags ETFs
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.